GenVec Inc (GNVC) - Financial and Strategic SWOT Analysis Review Summary GenVec Inc (GenVec) focuses on the research and development of gene-based medicine. It develops therapeutics and vaccines using its proprietary adenovector gene delivery platform. The company’s lead product, CGF166 is licensed to Novartis Institutes and is in Phase I/II for the treatment of hearing loss and balance disorders. GenVec Inc Key Recent Developments: Nov 04,2016: GenVec Reports Third Quarter 2016 Financial ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.